Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

JSS Medical Research Inc. and Integrated Research Inc. in Montréal, Québec, Canada completes the strategic merger of the two companies to become the largest Canadian owned CRO

Canada NewsWire January 7, 2014

UMD Researcher Helps Arm the Immune System to Fight Cancer

PR Newswire January 7, 2014

Tech Council of Maryland Releases 2014 Legislative Priorities for Life Sciences and Technology

Business Wire January 7, 2014

DoD's BioDefense Therapeutics Announces First Patient Enrolled in Phase 3 Clinical Trials for Favipiravir

PR Newswire January 7, 2014

Cellectis Reorganizes Its Tools and Services Business Line, in Partnership with Caisse Des Dépôts, by Contributing Ectycell's Shares to Cellectis Bioresearch

Business Wire January 7, 2014

Staples Announces Broad Expansion of Staples Connect Home and Office Automation Program

Marketwired January 7, 2014

One Laptop per Child and Vivitar Unveil Second Generation of Award-Winning XO Tablets

PR Newswire January 7, 2014

AIT Announces Phase II Study of NOxCureCF, a Respiratory Treatment for Cystic Fibrosis Patients Using a Nitric Oxide-Base Formulation

PR Newswire January 7, 2014

Keck School of Medicine of USC To Host Lectures By Winners Of The 2013 Lasker Awards

PR Newswire January 7, 2014

OraSure Technologies Addresses FDA Warning Letter Received by Its Subsidiary DNA Genotek

Globe Newswire January 7, 2014

Independent Data Monitoring Committee Recommends Early Stopping of Phase 3 Study of Ibrutinib in Relapsed/Refractory CLL/SLL Patients Based on a Planned Interim Analysis

PR Newswire January 7, 2014

Maverix Biomics Closes $6 Million Series A Round for Proven Gene Expression Data Analysis Company

PR Newswire January 7, 2014

Independent Data Monitoring Committee recommends Phase III study of IMBRUVICA(TM) (ibrutinib) versus ofatumumab be stopped early based on statistically significant improvement in progression free survival and overall survival

PR Newswire January 7, 2014

Compugen to Significantly Expand Immuno-Oncology Activities During 2014

Business Wire January 7, 2014

WaferGen Bio-systems Acquires a Leading Next-Generation Sequencing (NGS) Library Preparation Business and Announces Changes to its Board of Directors

PR Newswire January 7, 2014

Cortice Biosciences Announces the Appointment of George Farmer, Ph.D. as Chief Executive Officer

Globe Newswire January 7, 2014

LifeSci Advisors Initiates Coverage of ZS Pharma

Marketwired January 7, 2014

Navigating Cancer Announces Milestones Related to Patient Education Program

PR Newswire January 7, 2014

DNA Brings Fresh, Compelling Message to Golden 1 Credit Union with "Stronger Together" Campaign

Business Wire January 7, 2014

Karyopharm Therapeutics Announces Submission of New Animal Drug Application Effectiveness and Safety Sections for Novel, Oral, Small-Molecule Selective Inhibitor of Nuclear Export (SINE) Verdinexor for Canine Lymphoma to FDA's Center for Veterinary Medicine

Globe Newswire January 7, 2014